Survival-associated heterogeneity of marker-defined perivascular cells in colorectal cancer
- PMID: 27248825
- PMCID: PMC5173107
- DOI: 10.18632/oncotarget.9632
Survival-associated heterogeneity of marker-defined perivascular cells in colorectal cancer
Abstract
Perivascular cells (PC) were recently implied as regulators of metastasis and immune cell activity. Perivascular heterogeneity in clinical samples, and associations with other tumor features and outcome, remain largely unknown.Here we report a novel method for digital quantitative analyses of vessel characteristics and PC, which was applied to two collections of human metastatic colorectal cancer (mCRC).Initial analyses identified marker-defined subsets of PC, including cells expressing PDGFR-β or α-SMA or both markers. PC subsets were largely independently expressed in a manner unrelated to vessel density and size. Association studies implied specific oncogenic mutations in malignant cells as determinants of PC status. Semi-quantitative and digital-image-analyses-based scoring of the NORDIC-VII cohort identified significant associations between low expression of perivascular PDGFR-α and -β and shorter overall survival. Analyses of the SPCRC cohort confirmed these findings. Perivascular PDGFR-α and -β remained independent factors for survival in multivariate analyses.Overall, our study identified host vasculature and oncogenic status as determinants of tumor perivascular features. Perivascular PDGFR-α and -β were identified as novel independent markers predicting survival in mCRC. The novel methodology should be suitable for similar analyses in other tumor collections.
Keywords: PDGFR; cancer associated fibroblasts; colorectal cancer; perivascular cells; tumor stroma.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures




Similar articles
-
Multi-parametric profiling of renal cell, colorectal, and ovarian cancer identifies tumour-type-specific stroma phenotypes and a novel vascular biomarker.J Pathol Clin Res. 2017 Jul 24;3(3):214-224. doi: 10.1002/cjp2.74. eCollection 2017 Jul. J Pathol Clin Res. 2017. PMID: 28770105 Free PMC article.
-
Perivascular PDGFR-β is an independent marker for prognosis in renal cell carcinoma.Br J Cancer. 2017 Jan 17;116(2):195-201. doi: 10.1038/bjc.2016.407. Epub 2016 Dec 8. Br J Cancer. 2017. PMID: 27931046 Free PMC article.
-
Prognostic impact of platelet-derived growth factors in non-small cell lung cancer tumor and stromal cells.J Thorac Oncol. 2008 Sep;3(9):963-70. doi: 10.1097/JTO.0b013e3181834f52. J Thorac Oncol. 2008. PMID: 18758297
-
Clinically relevant biomarkers to select patients for targeted inhibitor therapy after resection of hepatocellular carcinoma.Ann Surg Oncol. 2011 Nov;18(12):3384-90. doi: 10.1245/s10434-011-1775-3. Epub 2011 May 18. Ann Surg Oncol. 2011. PMID: 21590454
-
Analysis of stromal PDGFR-β and α-SMA expression and their clinical relevance in brain metastases of breast cancer patients.BMC Cancer. 2023 May 22;23(1):468. doi: 10.1186/s12885-023-10957-5. BMC Cancer. 2023. PMID: 37217880 Free PMC article.
Cited by
-
Multi-parametric profiling of renal cell, colorectal, and ovarian cancer identifies tumour-type-specific stroma phenotypes and a novel vascular biomarker.J Pathol Clin Res. 2017 Jul 24;3(3):214-224. doi: 10.1002/cjp2.74. eCollection 2017 Jul. J Pathol Clin Res. 2017. PMID: 28770105 Free PMC article.
-
Tumor microenvironment complexity and therapeutic implications at a glance.Cell Commun Signal. 2020 Apr 7;18(1):59. doi: 10.1186/s12964-020-0530-4. Cell Commun Signal. 2020. PMID: 32264958 Free PMC article. Review.
-
Targeting glioblastoma-derived pericytes improves chemotherapeutic outcome.Angiogenesis. 2018 Nov;21(4):667-675. doi: 10.1007/s10456-018-9621-x. Epub 2018 May 14. Angiogenesis. 2018. PMID: 29761249 Free PMC article. Review.
-
Perivascular PDGFR-β is an independent marker for prognosis in renal cell carcinoma.Br J Cancer. 2017 Jan 17;116(2):195-201. doi: 10.1038/bjc.2016.407. Epub 2016 Dec 8. Br J Cancer. 2017. PMID: 27931046 Free PMC article.
-
Targeted molecular profiling of genetic alterations in colorectal cancer using next-generation sequencing.Oncol Lett. 2020 Feb;19(2):1137-1144. doi: 10.3892/ol.2019.11203. Epub 2019 Dec 10. Oncol Lett. 2020. PMID: 31966042 Free PMC article.
References
-
- Armulik A, Genove G, Betsholtz C. Pericytes: Developmental, Physiological, and Pathological Perspectives, Problems, and Promises. Dev Cell. 2011;21:193–215. - PubMed
-
- Dulauroy S, Di Carlo SE, Langa F, Eberl G, Peduto L. Lineage tracing and genetic ablation of ADAM12(+) perivascular cells identify a major source of profibrotic cells during acute tissue injury. Nat Med. 2012;18:1262–1270. - PubMed
-
- Goritz C, Dias DO, Tomilin N, Barbacid M, Shupliakov O, Frisen J. A Pericyte Origin of Spinal Cord Scar Tissue. Science. 2011;333:238–242. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous